中国实用外科杂志 ›› 2010, Vol. 30 ›› Issue (04): 275-277.
• 专家笔谈 • 上一篇 下一篇
蔡建强
出版日期:
发布日期:
Online:
Published:
摘要:
外科手术目前仍是胃肠间质瘤(GIST)病人获得根治的最佳手段,但术后复发转移是GIST病人治疗失败及死亡的主要原因。对于复发性GIST,外科治疗并不是最佳选择,应联合酪氨酸激酶抑制剂甲磺酸伊马替尼,结合病人的不同情况,个体化制定综合治疗方案,以提高病人总生存期。
关键词: 胃肠间质瘤, 甲磺酸伊马替尼
Abstract:
Reoperation for recurrent gastrointestinal stromal tumors CAI Jian-qiang. Department of Abdominal Surgical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China Abstract Surgical resection is still the primary curative treatment for gastrointestinal stromal tumor(GIST) patients. However, postoperative recurrence and metastasis of tumors are the major causes of treatment failure and patients death. Surgery is not the best choice for recurrent GIST. It is considerable to combine surgical and molecular therapy to increase the overall survival of GIST patients.
Key words: gastrointestinal stromal tumor (GIST), imatinib mesylate
蔡建强. 复发性胃肠间质瘤再次手术[J]. 中国实用外科杂志, 2010, 30(04): 275-277.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.zgsyz.com/zgsywk/CN/
https://www.zgsyz.com/zgsywk/CN/Y2010/V30/I04/275